BiVACOR

BiVACOR is a clinical-stage medical device company headquartered in Huntington Beach, California, focused on developing long-term therapeutic solutions for patients suffering from biventricular heart failure. The company has created the BiVACOR Total Artificial Heart (TAH), a titanium-constructed, valveless artificial heart designed to replace the entire function of a failing heart. The BiVACOR TAH utilizes advanced magnetic levitation (MAGLEV) technology, which enables a single, magnetically levitated rotor to pump blood to both the body and the lungs.

BiVACOR's innovative approach to artificial heart design has garnered international recognition and has attracted significant funding and support from organizations like the National Institutes of Health, the Texas Heart Institute, and the Australian Government's Medical Research Future Fund. The company is currently conducting an FDA-approved first-in-human Early Feasibility Study (EFS) to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-transplant solution for patients with severe heart failure.

BiVACOR offers employees a generous vacation policy, starting with 80 hours per year for first-year employees and increasing to 136 hours upon 7 years of employment. Additionally, they provide an 80-hour PTO policy per year. While specific details regarding remote work or flexible schedules are not mentioned, the focus on vacation and PTO suggests that BiVACOR values employee time off and well-being, which could indicate a supportive environment for flexible work arrangements.

BiVACOR offers a comprehensive benefits package that includes health and welfare options, such as medical, dental, vision, and short-term and long-term disability. Their vacation and PTO policy is generous, with a starting vacation allotment of 80 hours per year and increasing annually up to 136 hours upon the seventh year of employment. They also provide a PTO policy with an additional 80 hours per year. BiVACOR boasts a 401(k) plan with both non-elective and elective options, including a 4% employer-only contribution and a 6% matching program. They round out their benefits with short-term and long-term incentives.

BiVACOR is a clinical-stage medical device company focused on developing long-term solutions for patients suffering from biventricular heart failure. They are dedicated to replacing hearts and restoring lives by providing a next-generation, life-extending solution for those with end-stage heart failure awaiting a transplant. Their innovative total artificial heart (TAH) is designed to completely replace the function of the native heart, offering a potential lifeline for patients facing a dire prognosis.

BiVACOR promotes a collaborative culture that values hard work and recognizes individual contributions. The company emphasizes a team-oriented environment where engineers, medical specialists, and business executives work together to advance the groundbreaking technology. They value diversity and inclusion, fostering an environment where everyone feels respected and appreciated.

BiVACOR is committed to creating an inclusive work environment for all employees. They believe in equal opportunity employment and base employment decisions on individual qualifications, job requirements, and business needs, regardless of race, color, marital status, sex, sexual orientation, gender identity, age, religion, disability, citizenship status, national origin, pregnancy, veteran status, or any other legally protected characteristics. They are committed to providing reasonable accommodation for those who require it and encourage applications from all qualified individuals.